The firm is developing protein therapies incorporating synthetic amino acids coded for by "unnatural" base pairs developed at The Scripps Research Institute.
The company will work with a University of Copenhagen researcher to develop new synthetic peptide tools for the Syro Wave platform.
The firm sold its bioanalytical and genetic testing businesses to Bostwick Labs as it preps to buy peptide maker GL Biochem.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.